← Back to Clinical Trials
Recruiting NCT07805330

NCT07805330 Effects of Blood Flow Restriction Rehabilitation on Functional Mobility and Balance Among Chronic Obstructive Pulmonary Disease Patients.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07805330
Status Recruiting
Phase —
Sponsor Rashid Latif Medical College
Condition Chronic Obstructive Pulmonary Disease (COPD)
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-06-24
Primary Completion 2026-09-24

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Resistance Exercise without tourniquetBlood flow restriction resistance exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-06-24 with a primary completion date of 2026-09-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: Chronic obstructive pulmonary disease (COPD) is a common lung disease causing restricted airflow and breathing problems. It is sometimes called emphysema or chronic bronchitis. The damage results in swelling and irritation, also called inflammation, inside the airways that limit airflow into and out of the lungs. BFR Rehabilitation is effective in improving functional mobility and balance among COPD patients. Objective: To find out the effects of Blood Flow Restriction (BFR) Rehabilitation on functional mobility and balance among COPD (Chronic Obstructive Pulmonary Disease) patients. Methods: A Randomized Controlled Trial Study was conducted at Gulab Devi Hospital, Hameed Latif Hospital and Arif Memorial Teaching Hospital Lahore. Fifty patients of age 45-60 years with COPD were randomized into two groups. Allocation of patients in two equal groups by lottery method will be through random assignment. Group A was treated with controlled physical therapy while Group B was treated with BFR rehabilitation. Controlled treatment includes low intensity resistance exercises while BFR Rehabilitation includes use of a tourniquet with low intensity resistance exercises. All this information will be collected through a pulse oximeter. Berg Balance Scale will be used for balance and timed up and go test for functional mobility.

Eligibility Criteria

Inclusion Criteria: * Subjects who are clinically stable before study * Forced expiratory volume in 1s (FEV1)/forced vital capacity (FVC)\<70% and FEV1 ≥30% but \<80% respectively * Subjects who will be willing to take part in this study Exclusion Criteria: * Upper abdominal surgery * Lung cancer * Open fracture * Mental disorder * Active malignancy * Severe hypertension

Contact & Investigator

Central Contact

Aleena Waheed, Masters in Physical Therapy

✉ alwaheed28@gmail.com

📞 03214883868

Principal Investigator

Harmeen Nadeem

PRINCIPAL INVESTIGATOR

Arif Memorial Teaching Hospital

Frequently Asked Questions

Who can join the NCT07805330 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07805330 currently recruiting?

Yes, NCT07805330 is actively recruiting participants. Contact the research team at alwaheed28@gmail.com for enrollment information.

Where is the NCT07805330 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07805330 clinical trial?

NCT07805330 is sponsored by Rashid Latif Medical College. The principal investigator is Harmeen Nadeem at Arif Memorial Teaching Hospital. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology